“$2,500,000 to Cerus Corporation for Blood Safety and Decontamination Technology”
Sponsors:
Recipient Web Site:
Recipient Address:
(Flag)
2411 Stanwell Drive
Concord,
CA
94520
Recipient address as provided by Sponsor(s): (courtesy of Taxpayers for Common Sense)
2411 Stanwell Drive Concord, CA
Short Description of Recipient Organization:
Cerus Corporation is a biopharmaceutical company focused on the development and commercialization of the INTERCEPT Blood System. The INTERCEPT system is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. The company currently markets the INTERCEPT system for both platelets and plasma in Europe and, through distributors and licensees, in countries around the world that recognize the CE mark. The company is also in Phase I clinical trials for development of the INTERCEPT system for red blood cells in the United States.
Does the Recipient have Federal Contracts?
No
Does the Recipient have Federal Grants?
Yes
Link to the Recipient's Federal Grants (Fedspending.org):
Have employees of the recipient collectively contributed more than $20,000 to candidates for federal office during the current and last election cycle?:
Yes
Does a sponsoring member take credit?
No
Did the recipient hire federal lobbyists?
Yes
URL of Lobbying Data from OpenSecrets
Research contributed by:
